These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6976016)

  • 1. Activated factor IX complex in treatment of surgical cases of hemophilia A with inhibitors.
    Hanna WT; Madigan RR; Miles MA; Lange RD
    Thromb Haemost; 1981 Oct; 46(3):638-41. PubMed ID: 6976016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The problem of factor VIII inhibitors in patients with congenital coagulopathies].
    Klare M
    Z Gesamte Inn Med; 1983 Jan; 38(2):47-50. PubMed ID: 6407220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B.
    Djulbegovic B; Marasa M; Pesto A; Kushner GM; Hadley T; Joseph G; Goldsmith G
    Am J Hematol; 1996 Feb; 51(2):168-70. PubMed ID: 8579061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tooth extraction in patients suffering from hemophilia A under the cover of cryoprecipitates and epsilon-aminocaproic acid].
    Pniejnia-Olszyński W; Pietrzykowska E; Lopaciuk S
    Acta Haematol Pol; 1979; 10(2):123-8. PubMed ID: 474045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inhibitor coagulant complex (Autoplex) in hemophilia inhibitor patients undergoing synovectomy.
    Hutchinson RJ; Penner JA; Hensinger RN
    Pediatrics; 1983 Apr; 71(4):631-3. PubMed ID: 6601258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery on patients with hemostatic disorders.
    Lekas MD; DiBenedetto J; Smith PS; Kantesaria KP
    Laryngoscope; 1982 Aug; 92(8 Pt 1):873-7. PubMed ID: 6808274
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of patients with hemophilia A having antibodies to factor VIII].
    Lopaciuk S; Ziemski JM
    Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
    Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
    Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of anterior compartment syndrome in two high responder factor VIII inhibitor patients with activated prothrombin complex concentrate.
    Christiansen SE; Ingerslev J; Wallevik K; Farsø F; Helmig O; Stenbjerg S
    Thromb Res; 1986 Jun; 42(5):707-12. PubMed ID: 3487140
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating antibodies in factor VIII deficiency hemophilia: report of case.
    Cudzinowski L
    ASDC J Dent Child; 1979; 46(1):54-6. PubMed ID: 283081
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of hemophilia complicated by inhibitors.
    Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
    Iizuka A; Kuwashima M; Nagao T
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811
    [No Abstract]   [Full Text] [Related]  

  • 17. [The successful use of FEIBA for treatment of intracranial hemorrhage in a patient of hemophilia B with inhibitor].
    Taki M; Inagaki M; Tomita Y; Miura T; Saito N; Meguro T; Yamada K
    Rinsho Ketsueki; 1985 Aug; 26(8):1300-5. PubMed ID: 3877831
    [No Abstract]   [Full Text] [Related]  

  • 18. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On treatment trials of hemophiliacs with epsilon-aminocaproic acid (Epsamon)].
    Fonio A
    Schweiz Med Wochenschr; 1966 Dec; 96(51):1723-6. PubMed ID: 5973382
    [No Abstract]   [Full Text] [Related]  

  • 20. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.